Association Between the Volume Transfer Constant (Ktrans) From Dynamic Contrast‐Enhanced Perfusion MR and HER2 Status in Breast Cancer Brain Metastases

ABSTRACT Background With the development of new human epidermal growth factor 2 (HER2)‐targeting therapies, a non‐invasive method of determining the HER2 status of breast cancer brain metastases can be of great clinical value, particularly given the risks of brain biopsy and the possibility of disco...

Descripció completa

Dades bibliogràfiques

Autors principals:	Jonathan R. Young, Luke N. Ledbetter, Julie A. Ressler, Mark S. Shiroishi, Joanne E. Mortimer, Daniel Schmolze, Mariko Fitzgibbons, Bihong T. Chen
Format:	Artigo
Idioma:	Inglês
Publicat:	Wiley 2025-10-01
Col·lecció:	Cancer Reports
Matèries:	brain metastasis breast cancer dynamic contrast‐enhanced (DCE) perfusion magnetic resonance imaging volume transfer constant (Ktrans)
Accés en línia:	https://doi.org/10.1002/cnr2.70354
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!